{"slideshow_credits": null, "snippet": "Earnings were down 8.6 percent on unfavorable foreign exchange rates, a big divestiture and competition to its new hepatitis C drug.", "abstract": "Johnson & Johnson reports first-quarter profit of $4.32 billion, down 8.6 percent from year-earlier period; results surpass Wall Street expectations; company reduces its full-year profit forecast to $6.04 to $6.19 a share, from $6.12 to $6.27.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/04/15/business/first-quarter-profit-falls-at-johnson-johnson.html", "lead_paragraph": "Earnings were down 8.6 percent on unfavorable foreign exchange rates, a big divestiture and competition to its new hepatitis C drug.", "headline": {"print_headline": "First-Quarter Profit Falls at Johnson & Johnson", "main": "First-Quarter Profit Falls at Johnson &amp; Johnson ", "content_kicker": "Business Briefing", "kicker": "Business Briefing"}, "_id": "552da5ae38f0d87fbef52bc2", "word_count": "68", "multimedia": [], "pub_date": "2015-04-15T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Johnson & Johnson", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Company Reports", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}